Biological Implications of a Stroke Therapy Based in Neuroglobin Hyaluronate Nanoparticles. Neuroprotective Role and Molecular Bases
Authors:
- María Ángeles PeinadoMPMaría Ángeles Peinado
- David OvelleiroDODavid Ovelleiro
- María Luisa del MoralMMMaría Luisa del Moral
- Raquel HernándezRHRaquel Hernández
- Esther Martínez-LaraEMEsther Martínez-Lara
- Eva SilesESEva Siles
- José Rafael PedrajasJPJosé Rafael Pedrajas
- María Luisa García-MartínMaría Luisa García-Martín
- Carlos CaroCCCarlos Caro
- Sebastián PeraltaSPSebastián Peralta
- María Encarnación MoralesMMMaría Encarnación Morales
- María Adolfina RuizMRMaría Adolfina Ruiz
Open Access
- 27 December 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (1) , 247
Abstract
Exogenous neuroprotective protein neuroglobin (Ngb) cannot cross the blood–brain barrier. To overcome this difficulty, we synthesized hyaluronate nanoparticles (NPs), able to deliver Ngb into the brain in an animal model of stroke (MCAO). These NPs effectively reached neurons, and were microscopically identified after 24 h of reperfusion. Compared to MCAO non-treated animals, those treated with Ngb-NPs showed survival rates up to 50% higher, and better neurological scores. Tissue damage improved with the treatment, but no changes in the infarct volume or in the oxidative/nitrosative values were detected. A proteomics approach (p-value < 0.02; fold change = 0.05) in the infarcted areas showed a total of 219 proteins that significantly changed their expression after stroke and treatment with Ngb-NPs. Of special interest, are proteins such as FBXO7 and NTRK2, which were downexpressed in stroke, but overexpressed after treatment with Ngb-NPs; and ATX2L, which was overexpressed only under the effect of Ngb. Interestingly, the proteins affected by the treatment with Ngb were involved in mitochondrial function and cell death, endocytosis, protein metabolism, cytoskeletal remodeling, or synaptic function, and in regenerative processes, such as dendritogenesis, neuritogenesis, or sinaptogenesis. Consequently, our pharmaceutical preparation may open new therapeutic scopes for stroke and possibly for other neurodegenerative pathologies.Keywords
Funding Information
- Ministerio de Economía y Competitividad (BFU-2016-80316-R)
This publication has 86 references indexed in Scilit:
- Sex differences in brain proteomes of neuron‐specific STAT3‐null mice after cerebral ischemia/reperfusionJournal of Neurochemistry, 2012
- Endocytosis and Endosomes at the Crossroads of Regulating Trafficking of Axon Outgrowth‐Modifying ReceptorsTraffic, 2011
- Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: An experimental studyJournal of Cerebral Blood Flow & Metabolism, 2011
- Neuroglobin protects nerve cells from apoptosis by inhibiting the intrinsic pathway of cell deathApoptosis, 2009
- Neuroglobin-overexpression alters hypoxic response gene expression in primary neuron culture following oxygen glucose deprivationNeuroscience, 2009
- Effects of Neuroglobin Overexpression on Acute Brain Injury and Long-Term Outcomes After Focal Cerebral IschemiaStroke, 2008
- N-WASP and the Arp2/3 Complex Are Critical Regulators of Actin in the Development of Dendritic Spines and SynapsesJournal of Biological Chemistry, 2008
- A Role for EHD4 in the Regulation of Early Endosomal TransportTraffic, 2008
- Neuroglobin: an endogenous neuroprotectantCurrent Opinion in Pharmacology, 2008
- Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemiaProceedings of the National Academy of Sciences, 2006